Acumen Pharmaceuticals Inc (ABOS) Options Open Interest

Monitoring ABOS open interest helps you see where real money is positioned on Acumen Pharmaceuticals Inc's options and which strikes are attracting the most commitment from traders. Acumen Pharmaceuticals Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ABOS options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ABOS options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Acumen Pharmaceuticals Inc to settle.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ABOS open interest is concentrated. Our scanner maps Acumen Pharmaceuticals Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Acumen Pharmaceuticals Inc's options open interest as the signal it is, not as an afterthought.